- Home
- EBF vs MNPR Comparison
EBF vs MNPR Comparison
Compare EBF & MNPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EBF | MNPR |
|---|---|---|
| Founded | 1909 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Office Equipment/Supplies/Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 467.2M | 421.0M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | EBF | MNPR |
|---|---|---|
| Price | $18.62 | $66.62 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 14 |
| Target Price | N/A | ★ $99.15 |
| AVG Volume (30 Days) | 220.9K | ★ 320.9K |
| Earning Date | 12-22-2025 | 11-13-2025 |
| Dividend Yield | ★ 5.37% | N/A |
| EPS Growth | ★ 5.01 | N/A |
| EPS | ★ 1.66 | N/A |
| Revenue | ★ $388,740,000.00 | N/A |
| Revenue This Year | $0.96 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $11.23 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $16.30 | $24.00 |
| 52 Week High | $22.01 | $105.00 |
Technical Indicators
Market Signals| Indicator | EBF | MNPR |
|---|---|---|
| Relative Strength Index (RSI) | 62.64 | 44.04 |
| Support Level | $17.70 | $57.86 |
| Resistance Level | $18.25 | $66.65 |
| Average True Range (ATR) | 0.40 | 5.04 |
| MACD | 0.01 | 0.35 |
| Stochastic Oscillator | 87.83 | 54.92 |
Price Performance
Historical ComparisonAbout EBF Ennis Inc.
Ennis Inc is a manufacturer and supplier of print products for the wholesale trade. The company's products include advertising specialties, business forms and supplies, commercial printing, eCommerce solutions, envelopes, labels and tags, and folders and packaging. Its products include snap sets, continuous forms, laser cut sheets, tags, labels, envelopes, integrated products, jumbo rolls, and pressure-sensitive products in short, medium and long runs under the following labels: Ennis, Royal Business Forms, Block Graphics, 360 Custom LabelsSM, ColorWorx, Enfusion, among others.
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.